Summary In vitro (FLC-Vt) or in vivo (FLC-V) passaged Friend erythroleukaemia cells of DBA/2 origin were tested for susceptibility to natural resistance (NR) in vivo or to NK cell activity in vitro. Scarcely oncogenic FLC-Vt cells were highly susceptible to in vivo NR (measured as rapid organ clearance or growth inhibition in lethally irradiated mice) or to in vitro NK attack. Conversely, highly oncogenic FLC-V cells were weakly susceptible to NR and to NK as well. These data seem to point out that natural immunity, which is up-regulated by endogenous or exogenous interferons, can play a significant role in surveillance against mouse leukaemic cells of retrovirus origin.
It has been reported that the in vivo tumour suppressive effects of interferon (IFN) against in vitro and in vivo passaged Friend erythroleukaemia cells (FLC-Vt and FLC-V, respectively), derived from DBA/2 mice infected with Friend virus, might involve activation of immune host's mechanism rather than acting directly on tumour cells (Belardelli et al., 1982a; Gresser et al., 1983 Gresser et al., , 1988 ). This hypothesis was based on the isolation of FLC clones differing for sensitivity to IFN-alpha-beta-induced antiproliferative effects under in vitro conditions (Affabris et al., 1982) . Using the highly tumorigenic or IFN-resistant (3C18) FLC-V clones it was demonstrated that exogenous IFN preparations could suppress FLC-V in vivo growth, irrespective of the differences in IFN sensitivity (Belardelli et al., 1982a; Gresser et al., 1988) . Moreover, it was observed that the low oncogenicity of both 745-and 3C18-FLC-Vt clones was due to host's reactivity enhanced by endogenous IFN, since pretreatment of mice with anti-IFN antibodies augmented FLC-Vt tumorigenicity (Gresser et al., 1983) .
Previous investigations were carried out to detect the possible origin of host's immune reactivity involved in the indirect antitumour effects of IFN. The results showed that in vivo natural resistance (NR) against both FLC-Vt (Iorio et al., 1986) and FLC-V clones could play a significant role in this system. The present study shows that the low oncogenic FLC-Vt clone is subjected to strong NR in syngeneic DBA/2 mice and is more susceptible to NR effectors as compared with the highly oncogenic FLC-V. Therefore the results of this investigation further support the concept that the level of oncogenicity of FLC is a function, at least in part, of their degree of susceptibility to host's natural immune systems.
Materials and methods
Mice Inbred DBA/2 (H/2d) mice of different ages (Charles River, Calco, Italy) were used.
Tumours IFN-alpha-beta-sensitive 745 or -resistant 3Cl8 clones, derived from DBA/2 committed erythroid stem cells infected with Friend leukaemia virus and passaged either in vivo or in vitro, were used (Affabris et al., 1982) . FLC-V were maintained in syngeneic DBA/2 mice by weekly serial intraperitoneal (i.p.) transplantation of neoplastic cells. FLCVt were routinely grown in RPMI-1640 medium supplemented with 10% fetal calf serum. FLC-Vt are considerably less tumorigenic when inoculated intraperitoneally (i.p.) or subcutaneously (s.c.) than FLC-V. The features of the two cell clones used have been extensively discussed elsewhere (Belardelli et al., 1984) .
Drugs
Polyinosinic-polycytidylic acid (poly I:C) was obtained from Sigma Chemical Company (St Louis, MO) and dissolved in 0.85% NaCl solution; carrageenan (iota-carrageenan) was obtained from Sigma Chemical Company (St Louis, MO) dissolved in 0.85% NaCl solution and heated in boiling water for 10min; cyclophosphamide was supplied by Dr V.L. Narayanan (Drug Synthesis and Chemistry Branch, Division of Cancer Treatment, NCI, NIH, Bethesda, MD) and dissolved in 0.85% NaCl solution.
Irradiation
Animals were subjected to total body irradiation using a cobalt-60 irradiator (Hot Spot MKIV, Harwell, England), delivering gamma-rays at the rate of 800Rmin-m.
Organ clearance of 125I-iodedeoxyuridine (12 5IUdR)-labelled cells The general procedure for this assay has been previously described (Riccardi et al., 1980) . Briefly 25 x 106 FLC-V or FLC-Vt in 50ml of RPMI 1640 medium supplemented with 10% fetal calf serum were incubated overnight at 37°C in a CO2 incubator in the presence of 5-10 ig of 5-fluoro-2'-deoxyuridine (FUdR), to prevent endogenous thymidine synthesis, and lOuCi of 125IUdR (5-iodo-2'-deoxyuridine) ( later the mice were inoculated with 0.5 pCi of 125IUdR in 0.25 ml of 0.85% NaCl solution. Spleens, livers and lungs were removed 3 h later and 125IUdR not incorporated into DNA was eluted by soaking the organs in 70% ethanol for 3 days (Bennett, 1972) . The incorporation of radioactivity was measured in a gamma scintillation counter. The 125IUdR uptake was expressed as the geometric mean of the percentage of the isotope injected. (See also Hofer & Hughes, 1970.) Cytotoxicity assay The activity of natural killer (NK) cells was determined in a 51Cr release assay, as previously described (Herberman et al., 1974) (Belardelli et al., 1984) . Tumour titration carried out in DBA/2 hosts confirms that the same differences can be observed after i.v. inoculation of both FLC-V or FLC-Vt (Table I ). All mice died after i.v. injection of 5 x 106 FLC-V and FLC-Vt, but the median survival time (MTS) was significantly higher in DBA/2 mice inoculated with FLC-Vt as compared with that of mice injected with FLC-V. When 106 cells were used for tumour challenge no animal death was detected in mice inoculated with FLC-Vt, whereas all mice challenged with FLC-V died with generalized leukaemia within 17 (745) Table II , the incidence of lethal growth in immunosuppressed mice was 100%, whereas the majority of non-treated mice survived beyond the 60-day observation period. Calculation of lytic units Dose-response curves were obtained by plotting the percentages of specific 51Cr release and the effector:target (E/T) ratios. The best fit curve for this function was found to be logarithmic in accordance with previous reports (Tentori et al., 1985) .
A lytic unit, LUn, was defined as the number of effector cells, extrapolated from the dose-response curve, required to achieve n% specific target cell lysis (Thorn & Herney, 1976 In the test for cell proliferation in lethally irradiated mice, the 125IUdR background (i.e. that of irradiated mice not subjected to lymphoma challenge) was substracted from the 125IUdR uptake of the test groups before calculations. For survival studies, the non-parametric Mann-Whitney U test was used.
Differences in cytolytic effects produced by NK effectors in various experimental conditions were evaluated taking into account the percent of specific cytotoxicity at all E/T ratios. Therefore P values were calculated using covariance analysis performed on the regression of the number of effector cells over the logs of the percentage of specific 51Cr release. Rapid in vivo elimination of 125IUdR-labelled FLC: age dependence and comparison between FLC-V and FLC-Vt Previous investigations pointed out that NR, measured as rapid clearance of prelabelled cells, is detectable against both FLC-Vt and FLC-V (Iorio et al., 1986 (Iorio et al., , 1989 . In the present study a comparison between NR against FLC-V and FLC-Vt in DBA/2 mice of different ages was performed. Mice were injected i.v. with 104 FLC-V or FLC-Vt, labelled with 125IUdR, and lung clearance capability, considered to be the most sensitive measure of NR (Riccardi et al., 1980) Comparison between the growth of graded numbers of FLC-V or FLC-Vt in lethally irradiated mice Previous studies (Kawano et al., 1986) (Iorio et al., 1978) . The results of the growth (4 days) of FLC-V or FLC-Vt injected i.v. into lethally irradiated DBA/2 mice are given in Table III . Using three different In vitro NK activity against FLC-V or FLC-Vt Splenic NK activity of normal or Poly I:C stimulated DBA/2 mice was tested against FLC-V or FLC-Vt. In accordance with previous observations (Belardelli et al., 1982a) FLC-V and FLC-Vt were resistant to NK-mediated lysis of spleen cells obtained from untreated DBA/2 mice (see footnote in Table V) . On the other hand, a higher, but limited susceptibility of FLC-Vt as compared with that of FLC-V was observed when effector cells were collected from Poly I:C stimulated donors (Table V) .
Discussion
The results of the present paper show that the scarcely oncogenic FLC-Vt clone is more susceptible to NR in vivo and in vitro as compared with the highly oncogenic FLC-V. This appears to be in line with the hypothesis that IFN could activate host-mediated mechanisms rather than directly acting on tumour cells (Gresser et al., 1983) . A series of investigations has been undertaken in order to elucidate the mechanism of the indirect effect of IFN on the in vivo growth of tumour cells. Using models different from FLC, Kataoka et al. (1984) demonstrated the involvement of T-cell immunity, Uno et al. (1985) evidenced a positive contribution of macrophages, and Hanna (1980) and Hanna & Fidler (1980 , 1981 observed that IFNs and IFN inducers could limit metastases in mice by stimulation of NK-cell system. However, other reports did not support the idea that host's immune mechanisms are involved in the indirect effect of IFN. Studies relative to the tumour model adopted in the present paper showed that IFN-induced FLC-V necrosis was not accompanied by host immunocyte infiltration (Belardelli et al., 1982b) . Therefore, it was proposed that IFNdependent elimination of tumour cells could be mediated by various biochemical mechanisms such as changes in the physicochemical conditions within the peritoneal cavity. Moreover, Proietti et al. (1986) , using 3 P-nuclear resonance spectroscopy examinations, hypothesised that IFN could exert some effects on FLC metabolism via altered host microenvironment with subsequent tumour cell degeneration.
Investigations performed in our laboratory (Iorio et al., 1986 (Iorio et al., , 1989 (Iorio et al., 1986 (Iorio et al., , 1989 (Table I) showed that FLC-V is more oncogenic than FLC-Vt when inoculated by the i.v. route, thus confirming the previous observations obtained injecting the same clones subcutaneously or intraperitoneally (Belardelli et al., 1984) . In addition the role of host's immunity was pointed out by the finding that resistance to FLC-Vt could be weakened by total-body irradiation or by pretreatment with an immunodepressive agent such as cyclophosphamide used at high dose (i.e. 200mgkg-1 i.p., Table II ).
The studies performed to measure the possible involvement of NR in vivo in the low oncogenicity of FLC-Vt show significantly higher rates in FLC-Vt or FLC-V clearance in adult young mice as compared with that observed in infant recipients, immature for NR (Figure 1) . Moreover, significantly higher amounts of radiolabelled cells were found in FLC-V injected young adult mice as compared with those detected in the hosts of the same age inoculated with FLCVt. No differences were present, instead, in infant nonimmunocompetent mice. Depression of NR by pharmacological manipulation of the host (i.e. treatment with cyclophosphamide, carrageenan or anti-Asialo-GM-1 serum) induced a decline in the ability of mice to clear FLC-V or FLC-Vt (Figure 2 ). It is conceivable that NR-depressive agents act directly on NR-effector cells, including lung macrophages and NR-accessory cells involved in the upregulation of the natural immune function, possibly including IFN-gamma-producing T-cells (Friedman & Vogel, 1983) .
The results of studies carried out measuring in vivo growth of FLC-V or FLC-Vt in lethally irradiated hosts are in accordance with data obtained measuring the rapid clearance of tumour cells. The proliferation of graded numbers of FLC-V was significantly higher than that observed for FLCVt (Table III) . Actually no growth of FLC-Vt was observed in untreated lethally irradiated DBA/2 hosts, whereas significant proliferation occurred in mice pretreated with immunodepressive agents (Table IV) .
Finally, the NK experiments in vitro confirmed that FLCVt is more susceptible than FLC-V to NK-mediated lysis. The observation that rapid in vivo clearance of FLC-Vt is markedly more efficient than in vitro killing by NK effector spleen cells, can be explained by at least two different hypotheses: (a) lung effector cells are more cytotoxic than splenocytes against FLC-Vt targets; (b) the kinetics of in vivo clearance of leukaemic cells results from a mechanism more complex than that underlying in vitro natural cell-mediated cytotoxicity. The data of increased susceptibility to NKmediated lysis of FLC-Vt vs FLC-V are consistent with a number of studies reporting that tumour cells become less tumorigenic (Liu et al., 1977; Morgan et al., 1979; Beer et al., 1983; Yamashina et al., 1986 ) and more easily lysed in vitro by NK cells (Sendo et al., 1975; Nunn et al., 1977) , following in vitro cultivation. This often seems to be due to increased immunogenicity presumably as a consequence of changes on the membrane surface (Liu et al., 1977; Morgan et al., 1979; Yamashina et al., 1986) . In fact, Amici et al. (1984) , studying cell surface glycoproteins of FLC-V and FLC-Vt, observed a modified type and/or rate of glycosylation of membrane proteins possibly responsible of the differences in oncogenicity.
In conclusion, the results of the present investigation point to an important role of NR in the defence against Friend virus erythroleukaemia cells, although the mechanism underlying the role played by IFN has not been directly and definitely elucidated. In any case our data provide further support to the studies on host's surveillance in Friend virusinduced leukaemogenesis. Kumar et al. (1974) and Bennett et al. (1976) suggested that the natural effector cells active in haemopoietic graft rejection by lethally irradiated mice are similar to those involved in 'genetic resistance' to Friend virus leukaemia cells. Indeed, adult mice depleted of functional NK cell activity and of reactivity against haemopoietic histocompatibility (Hh) type antigens with the bone-seeking isotope 89Sr are deficient in their ability to suppress Friend virus erythroleukaemogenesis. Moreover, Eckner et al. (1987) found that treatment with anti-Asialo-GM1 serum, capable of depressing NK and Hh-type reactivity, elicited the rapid development of dormant leukaemia induced with replicationdefective Friend polycythaemia-inducing spleens focusforming virus (SFFV,) . Enhanced expression of Hh type antigens, target for marrow graft rejection, was observed by Rossi et al. (1970) and Cudkowicz et al. (1972) in DBA/2 spleen cells after in vivo infection with Friend leukaemia virus. Finally NR, measured as growth in lethally irradiated mice, was observed by Afifi et al. (1986) against FLD-3 erythroleukaemia, induced by Friend virus in BALB/c mice.
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